Filing Details

Accession Number:
0000880771-11-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-24 12:31:37
Reporting Period:
2011-05-23
Filing Date:
2011-05-24
Accepted Time:
2011-05-24 12:31:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202695 S Dean Woodman 950 Tower Lane, Suite 900
Foster City CA 94404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-23 10,000 $5.26 80,000 No 4 M Direct
Common Stock Disposition 2011-05-23 10,000 $5.79 70,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2011-05-23 10,000 $0.00 10,000 $5.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Granted under the Issuer's 1995 Non-Employee Director Stock Option Plan.
  2. Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer.
  3. Option expiration date is May 31, 2011.